Literature DB >> 22306804

Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans?

P Edison1, R Hinz, A Ramlackhansingh, J Thomas, G Gelosa, H A Archer, F E Turkheimer, D J Brooks.   

Abstract

RATIONALE: (11)C]PIB is the most widely used PET imaging marker for amyloid in dementia studies. In the majority of studies the cerebellum has been used as a reference region. However, cerebellar amyloid may be present in genetic Alzheimer's (AD), cerebral amyloid angiopathy and prion diseases. Therefore, we investigated whether the pons could be used as an alternative reference region for the analysis of [(11)C]PIB binding in AD. The aims of the study were to: 1) Evaluate the pons as a reference region using arterial plasma input function and Logan graphical analysis of binding. 2) Assess the power of target-to-pons ratios to discriminate controls from AD subjects. 3) Determine the test-retest reliability in AD subjects. 4) Demonstrate the application of target-to-pons ratio in subjects with elevated cerebellar [(11)C]PIB binding.
METHODS: 12 sporadic AD subjects aged 65 ± 4.5 yrs with a mean MMSE 21.4 ± 4 and 10 age-matched control subjects had [(11)C]PIB PET with arterial blood sampling. Three additional subjects (two subjects with pre-symptomatic presenilin-1 mutation carriers and one probable familial AD) were also studied. Object maps were created by segmenting individual MRIs and spatially transforming the gray matter images into standard stereotaxic MNI space and then superimposing a probabilistic atlas. Cortical [(11)C]PIB binding was assessed with an ROI (region of interest) analysis. Parametric maps of the volume of distribution (V(T)) were generated with Logan analysis. Additionally, parametric maps of the 60-90 min target-to-cerebellar ratio (RATIO(CER)) and the 60-90 min target-to-pons ratio (RATIO(PONS)) were computed.
RESULTS: All three approaches were able to differentiate AD from controls (p<0.0001, nonparametric Wilcoxon rank sum test) in the target regions with RATIO(CER) and RATIO(PONS) differences higher than V(T) with use of an arterial input function. All methods had a good reproducibility (intraclass correlation coefficient>0.83); RATIO(CER) performed best closely followed by RATIO(PONS). The two subjects with presenilin-1 mutations and the probable familial AD case showed no significant differences in cortical binding using RATIO(CER), but the RATIO(PONS) approach revealed higher [(11)C]PIB binding in cortex and cerebellum.
CONCLUSION: This study established 60-90 min target-to-pons RATIOs as a reliable method of analysis in [(11)C]PIB PET studies where cerebellum is not an appropriate reference region. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306804     DOI: 10.1016/j.neuroimage.2012.01.099

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  16 in total

1.  Long-term Changes in 18F-Flutemetamol Uptake in Nondemented Older Adults.

Authors:  Kevin Duff; Kevin P Horn; John M Hoffman
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Apr-Jun       Impact factor: 2.703

2.  Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective.

Authors:  Sepideh Shokouhi; Desmond Campbell; Aaron B Brill; Harry E Gwirtsman
Journal:  Brain Pathol       Date:  2016-09       Impact factor: 6.508

3.  Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology.

Authors:  Renaud La Joie; Nagehan Ayakta; William W Seeley; Ewa Borys; Adam L Boxer; Charles DeCarli; Vincent Doré; Lea T Grinberg; Eric Huang; Ji-Hye Hwang; Milos D Ikonomovic; Clifford Jack; William J Jagust; Lee-Way Jin; William E Klunk; Julia Kofler; Orit H Lesman-Segev; Samuel N Lockhart; Val J Lowe; Colin L Masters; Chester A Mathis; Catriona L McLean; Bruce L Miller; Daniel Mungas; James P O'Neil; John M Olichney; Joseph E Parisi; Ronald C Petersen; Howard J Rosen; Christopher C Rowe; Salvatore Spina; Prashanthi Vemuri; Victor L Villemagne; Melissa E Murray; Gil D Rabinovici
Journal:  Alzheimers Dement       Date:  2018-10-19       Impact factor: 21.566

4.  Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.

Authors:  Adam S Fleisher; Kewei Chen; Yakeel T Quiroz; Laura J Jakimovich; Madelyn Gutierrez Gomez; Carolyn M Langois; Jessica B S Langbaum; Napatkamon Ayutyanont; Auttawut Roontiva; Pradeep Thiyyagura; Wendy Lee; Hua Mo; Liliana Lopez; Sonia Moreno; Natalia Acosta-Baena; Margarita Giraldo; Gloria Garcia; Rebecca A Reiman; Matthew J Huentelman; Kenneth S Kosik; Pierre N Tariot; Francisco Lopera; Eric M Reiman
Journal:  Lancet Neurol       Date:  2012-11-06       Impact factor: 44.182

Review 5.  Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.

Authors:  Gaël Chételat; Renaud La Joie; Nicolas Villain; Audrey Perrotin; Vincent de La Sayette; Francis Eustache; Rik Vandenberghe
Journal:  Neuroimage Clin       Date:  2013-03-05       Impact factor: 4.881

6.  PiB Fails to Map Amyloid Deposits in Cerebral Cortex of Aged Dogs with Canine Cognitive Dysfunction.

Authors:  Rikke Fast; Anders Rodell; Albert Gjedde; Kim Mouridsen; Aage K Alstrup; Carsten R Bjarkam; Mark J West; Mette Berendt; Arne Møller
Journal:  Front Aging Neurosci       Date:  2013-12-30       Impact factor: 5.750

7.  Quantitative amyloid imaging using image-derived arterial input function.

Authors:  Yi Su; Tyler M Blazey; Abraham Z Snyder; Marcus E Raichle; Russ C Hornbeck; Patricia Aldea; John C Morris; Tammie L S Benzinger
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

8.  Reference region automatic extraction in dynamic [(11)C]PIB.

Authors:  Yoko Ikoma; Paul Edison; Anil Ramlackhansingh; David J Brooks; Federico E Turkheimer
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

Review 9.  A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis.

Authors:  Daniela Perani; Perani Daniela; Orazio Schillaci; Schillaci Orazio; Alessandro Padovani; Padovani Alessandro; Flavio Mariano Nobili; Nobili Flavio Mariano; Leonardo Iaccarino; Iaccarino Leonardo; Pasquale Anthony Della Rosa; Della Rosa Pasquale Anthony; Giovanni Frisoni; Frisoni Giovanni; Carlo Caltagirone; Caltagirone Carlo
Journal:  Biomed Res Int       Date:  2014-03-19       Impact factor: 3.411

10.  Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.

Authors:  Tammie L S Benzinger; Tyler Blazey; Clifford R Jack; Robert A Koeppe; Yi Su; Chengjie Xiong; Marcus E Raichle; Abraham Z Snyder; Beau M Ances; Randall J Bateman; Nigel J Cairns; Anne M Fagan; Alison Goate; Daniel S Marcus; Paul S Aisen; Jon J Christensen; Lindsay Ercole; Russ C Hornbeck; Angela M Farrar; Patricia Aldea; Mateusz S Jasielec; Christopher J Owen; Xianyun Xie; Richard Mayeux; Adam Brickman; Eric McDade; William Klunk; Chester A Mathis; John Ringman; Paul M Thompson; Bernardino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Stephen Salloway; Stephen Correia; Peter R Schofield; Colin L Masters; Christopher Rowe; Victor L Villemagne; Ralph Martins; Sebastien Ourselin; Martin N Rossor; Nick C Fox; David M Cash; Michael W Weiner; David M Holtzman; Virginia D Buckles; Krista Moulder; John C Morris
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.